What is the most likely diagnosis of a 3mm nodule located in the fat anterior to the psoas muscle, identified three years after partial nephrectomy for a 1.3cm chromophobe renal cell carcinoma (RCC), which was present one month post-operatively and has since 'matured'?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: March 24, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Differential Diagnosis for the 3mm Nodule

  • Single most likely diagnosis
    • Benign fatty lesion (e.g., lipoma or fibrolipoma): The fact that the radiologist described the nodule as having "matured" over the past three years suggests a benign process. The location in the fat anterior to the psoas muscle and the small size of the nodule also support a benign fatty lesion.
  • Other Likely diagnoses
    • Reactive lymph node: Although the nodule is small, it could represent a reactive lymph node, especially given its location near the surgical bed. However, the lack of significant change in size over three years makes this less likely.
    • Fibrous pseudotumor: This is a benign lesion that can occur in the retroperitoneum and could be considered given the nodule's location and stability over time.
  • Do Not Miss (ddxs that may not be likely, but would be deadly if missed.)
    • Metastatic disease (e.g., RCC metastasis to a lymph node): Although the primary tumor was small and low-stage, there is always a possibility of metastatic disease, especially in the context of a history of cancer. The fact that the nodule was not present before surgery but appeared shortly after raises some concern.
    • Sarcomatoid transformation or dedifferentiation: Although the original tumor did not have sarcomatoid features, there is a small chance of transformation or dedifferentiation, which could manifest as a new nodule.
  • Rare diagnoses
    • Soft tissue sarcoma: This is a rare possibility, but it could be considered given the nodule's location in the soft tissues. However, the lack of significant growth over three years makes this less likely.
    • Other rare benign lesions (e.g., schwannoma, neurofibroma): These lesions are rare and would be unlikely given the clinical context, but they could be considered if other diagnoses are ruled out.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.